![]() |
市場調查報告書
商品編碼
1820083
2025-2033年人工水晶體市場報告(依產品、材料(聚甲基丙烯酸甲酯、矽膠、疏水性壓克力)、最終用途和地區)Intraocular Lens Market Report by Product, Material (Polymethylmethacrylate, Silicone, Hydrophobic Acrylic), End Use, and Region 2025-2033 |
2024年,全球人工水晶體市場規模達44億美元。展望未來, IMARC Group預計到2033年,該市場規模將達到65億美元,2025-2033年期間的複合年成長率(CAGR)為4.31%。在先進的醫療基礎設施和持續的技術創新的推動下,北美將在2024年佔據市場主導地位。老齡化人口的不斷成長、白內障發病率的上升,以及全球眼保健意識和可及性的不斷提高,共同推動了對先進外科手術干預的需求,從而推動了人工晶狀體市場佔有率的成長。
市場驅動力源自於患者對先進視力矯正方案(例如多焦點和散光晶體)日益成長的認知。與生活方式相關的眼部疾病日益增多,尤其是長時間接觸螢幕導致的眼部疾病,導致需要手術介入的視力障礙。保險覆蓋範圍的擴大和眼科手術的優惠報銷政策,使得人工水晶體(IOL)更容易被更廣泛的人群接受。此外,年輕族群中選擇性視力矯正的屈光性水晶體置換趨勢正在擴大市場基礎。製造商和眼科醫師加強行銷力度,強調先進人工水晶體的益處,也影響病患的選擇。此外,手術安全性和療效的改善也鼓勵更多人選擇人工水晶體置換手術。
白內障盛行率不斷上升
白內障盛行率不斷上升,尤其是在老年人口中,是市場的主要驅動力。根據美國疾病管制與預防中心 (CDC) 的數據,到 2028 年,預計美國將有超過 3,000 萬人罹患白內障。白內障會導致自然水晶體混濁,進而導致視力障礙,只能透過手術矯正。隨著全球老年人口的成長,白內障手術的數量顯著增加,推動了對人工水晶體的需求。提供免費或補貼白內障手術的公共衛生措施和政府計畫使治療更加可及。隨著手術技術的改進和成功率的提高,越來越多的患者選擇白內障摘除,這直接推動了全球人工水晶體的普及。
擴建眼科護理中心
眼科護理中心的擴張有助於提高專科眼科治療的可近性。 2025年7月,由董事長兼董事總經理D. Ramamurthy創立的超級專科眼科醫院網路-眼科基金會(Eye Foundation),在印度欽奈的瓦達帕拉尼(Vadapalani)開設了第25家機構。該中心提供專業服務,例如採用優質人工水晶體(IOL)和尖端LASIK(如SILK和Femto)技術的雷射白內障手術。隨著越來越多的醫院、診所和專門的眼科護理機構在城鄉地區開設,越來越多的人可以接受白內障和屈光手術。這些基礎設施的改善使得及時診斷和治療成為可能,這對於像白內障這樣需要手術干預的疾病至關重要。先進護理中心的出現正在增強患者對手術的信心,並鼓勵更多人選擇視力矯正。
技術進步
技術進步推動市場成長,為患者提供更佳的視覺效果和更豐富的客製化選擇。多焦點、景深擴展、散光晶體和調節型人工水晶體等創新技術,為老花眼和散光提供了更佳的矯正效果,減少了對眼鏡的依賴。水晶體材料的進步增強了生物相容性,減少了術後併發症,而飛秒雷射輔助白內障手術等精密手術技術則提高了植入的準確性。 2025年1月,億博醫療科技(北京)有限公司及其子公司宣布,其生產的有晶狀體人工水晶體「龍晶PR」已獲得國家藥品監督管理局(NMPA)頒發的三類醫療器材註冊證。龍晶PR採用先進的均衡丙烯酸材料製成,具有零球面像差佈局、廣闊的光學區域和穩定的雙凹拱高配置。除此之外,數位成像和基於人工智慧 (AI) 的規劃工具的整合使外科醫生能夠根據個別患者需求實現最佳屈光效果。
與生活方式相關的眼部疾病激增
因長時間面對螢幕而導致的生活方式相關眼部疾病發病率不斷上升,這為市場帶來了良好的前景。過度使用電腦、智慧型手機和數位設備會導致眼睛疲勞、眼乾澀和視力加速衰退,導致水晶體相關疾病的提早發生。如今,年輕人正經歷傳統上困擾老年人的視力障礙,這擴大了人工水晶體手術的潛在患者群體。此外,持續暴露於藍光和減少戶外活動會影響整體眼部健康,因此需要進行矯正手術。眼科護理專業人士建議及時進行手術干預以恢復視力,這通常涉及植入先進的人工水晶體。這種生活方式的轉變正在催化對矯正眼部手術的持續需求,從而推動市場成長。
人們對高級視力矯正方案的認知不斷提高
隨著患者尋求長期恢復清晰視力的方案,人們對先進視力矯正方案的認知不斷提高,這推動了人工水晶體(IOL)的需求。教育計畫和社群媒體的推廣使人們對白內障手術和屈光性水晶體置換術有了更多的了解。許多人意識到,IOL不僅可以治療白內障,還可以矯正近視、遠視和散光等屈光不正。眼科醫師的口碑推薦、客戶評價和透明溝通進一步增強了人們對這些手術的信任。隨著患者了解到可以減少對眼鏡依賴的優質水晶體類型,他們更有可能儘早選擇手術介入。這種認知的提升,加上健康意識的增強,直接轉化為更高的採用率,從而推動市場穩定成長。
擴大眼科治療的保險覆蓋範圍
眼科治療保險覆蓋率的提高對市場產生了積極影響,因為它顯著降低了視力矯正手術的經濟門檻。許多健康保險涵蓋白內障手術的部分或全部費用,包括人工水晶體(IOL)的費用。這使得更廣泛的人群,包括退休人員和低收入患者,更容易獲得先進的人工水晶體選擇。一些國家的報銷政策也鼓勵及時手術,防止視力喪失並改善生活品質。透過減輕自付費用,保險覆蓋範圍使患者能夠選擇具有增強視覺功能的優質人工水晶體。這不僅提高了市場滲透率,也增加了每次手術的平均收入。隨著保險政策不斷擴大其眼科治療的覆蓋範圍,預計對人工水晶體的需求將穩步成長。
The global intraocular lens market size reached USD 4.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.5 Billion by 2033, exhibiting a growth rate (CAGR) of 4.31% during 2025-2033. North America dominates the market in 2024, driven by advanced healthcare infrastructure and continual technological innovations. The growing aging population with increased cataract incidence and rising global awareness and accessibility to eye care are collectively driving the demand for advanced surgical interventions, thereby propelling the intraocular lens market share.
The market is driven by the growing awareness among patients about advanced vision correction options, such as multifocal and toric lenses. Rising lifestyle-related eye conditions, particularly due to prolonged screen exposure, are contributing to vision impairments requiring surgical intervention. Increasing insurance coverage and favorable reimbursement policies for eye surgeries are making IOLs more accessible to a broader population. Additionally, the trend of refractive lens exchange for elective vision correction among younger individuals is widening the market base. Greater marketing efforts by manufacturers and ophthalmologists to highlight the benefits of advanced IOLs are also influencing patient choices. Furthermore, improvements in surgical safety and outcomes are encouraging more people to opt for lens replacement procedures.
Increasing prevalence of cataracts
Rising prevalence of cataracts, especially among the aging population, is a major driver for the market. As per the Centers for Disease Control and Prevention (CDC), by the year 2028, it is anticipated that more than 30 Million individuals will be affected by cataracts in the United States. Cataracts cause clouding of the natural lens, leading to vision impairment that can only be corrected through surgery. As the global elderly demographic is growing, the number of cataract surgeries is increasing significantly, driving the demand for IOLs. Public health initiatives and government programs offering free or subsidized cataract surgeries are making treatments more accessible. With improved surgical techniques and higher success rates, more patients are opting for cataract removal, directly fueling the adoption of IOLs worldwide.
Expansion of ophthalmic care centers
The broadening of ophthalmic care centers is aiding in improving accessibility to specialized eye treatments. In July 2025, the Eye Foundation, a network of super-speciality eye hospitals established by D. Ramamurthy, chairman and managing director, inaugurated its 25th facility in Vadapalani, Chennai, India. The center provided specialized services, such as laser cataract surgery featuring premium IOLs and cutting-edge LASIK technologies like SILK and Femto. With more hospitals, clinics, and dedicated eye care facilities opening in both urban and rural areas, a larger population can undergo cataract and refractive surgeries. This improved infrastructure enables timely diagnosis and treatment, which is crucial for conditions like cataracts that require surgical intervention. The presence of advanced care centers is boosting patient confidence in surgical procedures, encouraging more individuals to opt for vision correction.
Technological advancements
Technological advancements are propelling the market growth by offering patients improved visual outcomes and greater customization options. Innovations, such as multifocal, extended depth-of-focus, toric lenses, and accommodating IOLs, provide better correction for presbyopia and astigmatism, reducing dependence on glasses. Advancements in lens materials enhance biocompatibility and reduce post-surgical complications, while precision surgical techniques like femtosecond laser-assisted cataract surgery increase implantation accuracy. In January 2025, Yebright Medical Technology (Beijing) Co., Ltd., along with its subsidiaries, declared that its Phakic IOL, 'Loong Crystal PR,' obtained the Class III Medical Devices Certificate from the National Medical Products Administration (NMPA). Made from an advanced, balanced acrylic material, the Loong Crystal PR featured a zero spherical aberration layout with an extensive optical zone and a stable double concave arch height configuration. Besides this, the integration of digital imaging and artificial intelligence (AI)-based planning tools allows surgeons to achieve optimal refractive results tailored to individual patient needs.
Surge in lifestyle-related eye conditions
Increasing incidence of lifestyle-related eye conditions caused by prolonged screen time is offering a favorable market outlook. Excessive use of computers, smartphones, and digital devices leads to eye strain, dry eyes, and accelerated vision deterioration, contributing to the earlier onset of lens-related disorders. Younger individuals are now experiencing vision impairment that traditionally affected older adults, expanding the potential patient base for IOL surgeries. Additionally, constant exposure to blue light and reduced outdoor activities are known to affect overall eye health, necessitating corrective procedures. Eye care professionals are recommending timely surgical interventions to restore vision, which often involve the implantation of advanced IOLs. This lifestyle shift is catalyzing sustained demand for corrective eye surgeries, thereby fueling the market growth.
Growing awareness about advanced vision correction options
Rising awareness about advanced vision correction options is driving the demand for IOLs, as patients are seeking long-term solutions to restore clear vision. Educational programs and social media outreach have made people more informed about cataract surgery and refractive lens exchange. Many individuals are understanding that IOLs not only treat cataracts but can also correct refractive errors like myopia, hyperopia, and astigmatism. Word-of-mouth recommendations, testimonials, and transparent communication from ophthalmologists further build trust in these procedures. As patients are learning about the availability of premium lens types offering reduced dependence on glasses, they are more likely to choose surgical intervention earlier. This heightened awareness, combined with increased health consciousness, is directly translating into higher adoption rates, thereby impelling steady market growth.
Increasing insurance coverage for eye treatments
Rising insurance coverage for eye treatments is positively influencing the market, as it significantly reduces the financial barrier to vision correction surgeries. Many health insurance policies include partial or full coverage for cataract procedures, including the cost of IOLs. This makes advanced lens options more accessible to a broader demographic, including retirees and low-income patients. Reimbursement policies in several countries also encourage timely surgery, preventing vision loss and improving quality of life. By alleviating out-of-pocket expenses, insurance coverage allows patients to opt for premium IOLs with enhanced visual performance. This is not only boosting the market penetration but also increasing the average revenue per surgery. As insurance policies continue to expand their scope for ophthalmic treatments, the demand for IOLs is expected to grow steadily.
Multifocal IOL account for the majority of the market share
Multifocal IOLs dominate the market as the largest segment, offering a comprehensive solution to age-related vision issues. These lenses provide multiple focal points, allowing patients to achieve clear vision at various distances, reducing dependence on glasses after cataract surgery. With an aging population seeking enhanced visual acuity for both near and far distances, multifocal IOLs have gained prominence. The versatility they offer aligns with the lifestyle demands of individuals desiring improved vision across different activities, from reading to driving, making them a preferred choice in the market.
Monofocal IOLs represent a significant segment of the market, serving as a traditional and cost-effective option for cataract surgery. These lenses have a single focal point, typically set for distance vision, necessitating the use of glasses for activities requiring near vision. While lacking multifocal versatility, monofocal IOLs remain popular due to their reliability and affordability, catering to patients with specific visual needs and budget constraints.
Toric IOLs address astigmatism, a common refractive error, making them a crucial segment in the market. These lenses correct both cataracts and astigmatism simultaneously, enhancing visual outcomes for patients with irregular corneal shapes. With an increasing prevalence of astigmatism globally, toric IOLs have witnessed growing demand, offering patients the opportunity to achieve better visual clarity without additional surgical interventions or reliance on corrective eyewear.
Accommodative IOLs represent an innovative segment designed to mimic the eye's natural ability to adjust focus. These lenses provide a dynamic range of vision by changing shape and position within the eye. While still evolving, accommodative IOLs aim to reduce dependency on glasses for both near and distant vision. As technological advancements continue, this segment holds promise for individuals seeking a more adaptive and natural visual experience post-cataract surgery.
Hydrophobic acrylic holds the largest share of the industry
Hydrophobic acrylic has emerged as the largest segment in the market due to its superior optical properties and biocompatibility. These lenses are known for their resistance to protein and water deposits, reducing the likelihood of postoperative complications. Hydrophobic acrylic IOLs provide excellent clarity and are suitable for various surgical techniques. Surgeons often prefer this material for its ease of handling and the reduced risk of posterior capsule opacification (PCO), contributing to the widespread adoption of hydrophobic acrylic lenses in modern cataract surgeries. The material's ability to maintain optical clarity over time and resist clouding has solidified its position as a leading choice.
PMMA has been a traditional material in intraocular lenses (IOLs) and, while its usage has decreased with technological advancements, it still holds a notable segment in the market. PMMA lenses are rigid and durable, providing stability within the eye. However, their lack of flexibility and potential for certain postoperative complications have led to a decline in their popularity compared to more modern materials like hydrophobic acrylic and silicone.
Silicone lenses offer flexibility and biocompatibility, contributing to their prevalence in the market. Known for their softness and ability to fold easily, silicone lenses facilitate less invasive surgical procedures. The material's inert nature reduces the risk of inflammation and allergic reactions. While not as widely used as hydrophobic acrylic, silicone remains a significant choice, particularly in cases where the surgeon prioritizes lens flexibility and patient comfort.
Hospitals represent the leading market segment
Hospitals constitute the largest segment of the market, serving as primary hubs for surgical procedures, including cataract surgeries requiring IOL implantation. The comprehensive infrastructure and diverse medical specialties within hospitals make them central to the diagnosis and treatment of ocular conditions. The high patient footfall in hospitals, coupled with the availability of advanced surgical facilities, positions them as key contributors to the demand for intraocular lenses. Moreover, hospitals often attract a wide range of patients, including those with complex ocular conditions, making them pivotal in the overall market share.
On the other hand, ophthalmic clinics represent a significant segment of the market, offering specialized care focused on eye health. These clinics, led by ophthalmologists and optometrists, are key contributors to the diagnosis and treatment of various eye disorders, including cataracts. Ophthalmic clinics provide a more specialized and focused environment for eye care, attracting patients seeking expert advice and surgical interventions. The efficiency and expertise of these clinics contribute to their substantial share in the IOL market, particularly for routine and elective eye surgeries.
Moreover, ambulatory care centers play a notable role in the market, offering a balance between the comprehensive services of hospitals and the specialized care of ophthalmic clinics. These centers provide outpatient surgical procedures, including cataract surgery with this lens implantation. The convenience of ambulatory care centers, offering timely and efficient procedures without the need for overnight hospital stays, appeals to patients and contributes to the demand for these lenses outside traditional hospital settings.
Furthermore, eye research institutes are crucial contributors to the market. These institutions focus on advancing knowledge in ophthalmology, developing new surgical techniques, and conducting clinical trials for innovative intraocular lens technologies. The insights and advancements generated by eye research institutes influence the broader market, shaping the future of these lens materials, designs, and surgical approaches. While not primary end-users for routine surgeries, these institutes play a pivotal role in driving innovation and elevating the standards of care in the field of ophthalmology.
North America leads the market, accounting for the largest intraocular lens market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America dominates the market, driven by advanced healthcare infrastructure, a high prevalence of cataracts, and a rapidly aging population. The region's well-established reimbursement policies and a strong focus on technological innovations contribute to the widespread adoption of premium IOLs. The presence of key market players, coupled with a proactive approach toward eye health and surgical interventions, solidifies North America's leading position in the global IOL market.
The Asia Pacific region is a significant and growing market for intraocular lenses, fueled by a large population, increasing awareness of eye health, and rising access to healthcare services. The prevalence of age-related eye conditions, including cataracts, in countries like China and India, propels the demand for IOLs. Furthermore, advancements in healthcare infrastructure and the growing disposable income in several Asia Pacific nations contribute to the expansion of the market in the region.
Europe stands as a prominent market for these lenses, driven by a well-established healthcare system, a high prevalence of age-related eye disorders, and a growing emphasis on minimally invasive surgical techniques. The region's aging population contributes significantly to the demand for cataract surgeries and, consequently, intraocular lenses. European countries also exhibit a strong inclination toward adopting innovative medical technologies, fostering the growth of the market in the region.
Latin America represents a burgeoning market for intraocular lenses, propelled by improving healthcare infrastructure and a rising awareness of eye health. The region's aging demographic contributes to an increased incidence of cataracts, driving the demand for lens implantation. While the market is still developing, Latin America showcases substantial growth potential, with increasing investments in healthcare and a growing focus on addressing visual impairments.
The Middle East and Africa exhibit a growing demand for these lenses, driven by improving healthcare accessibility and rising awareness of eye disorders. Although the market is in the early stages of development compared to other regions, an aging population and increasing investments in healthcare infrastructure contribute to the expansion of the market. As these regions continue to advance in medical technology adoption, the demand for intraocular lenses is expected to rise, albeit at a pace influenced by regional economic factors and healthcare development.
The key players in the market are actively engaged in strategic initiatives to maintain and expand their market presence. Continuous research and development efforts are directed towards the enhancement of intraocular lens technologies, focusing on improving optical outcomes, durability, and patient satisfaction. Companies are investing in the development of innovative materials and designs, such as advanced hydrophobic acrylics and multifocal lenses, to address evolving patient needs. Additionally, strategic collaborations, partnerships, and acquisitions are prevalent among key players, enabling them to strengthen their product portfolios and leverage complementary technologies. Market leaders are also actively involved in geographic expansion, targeting emerging markets with growing healthcare infrastructures.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Purchase OptionsDiscount
Offer
Single User License